Clinical Relevance of Autoantibodies against Interleukin-2 in Patients with Systemic Lupus Erythematosus

BACKGROUND: Increased serum autoantibodies against interleukin-2 (anti-IL-2 autoantibodies) were reported in patients with systemic lupus erythematosus (SLE) and in patients receiving IL-2 therapy. This study aimed to explore the clinical relevance of serum anti-IL-2 autoantibodies and the interacti...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Miao, Sun, Xiao-Lin, Sun, He, He, Jing, Zhang, Rui-Jun, Zhang, Xia, Li, Zhan-Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032677/
https://www.ncbi.nlm.nih.gov/pubmed/29941704
http://dx.doi.org/10.4103/0366-6999.235114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032677/
https://www.ncbi.nlm.nih.gov/pubmed/29941704
http://dx.doi.org/10.4103/0366-6999.235114

Ejemplares similares